These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19604437)

  • 1. Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.
    Schimmel EK; Yazici Y
    Clin Exp Rheumatol; 2009; 27(3):446-51. PubMed ID: 19604437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR; Engstrand S; Berglin E; Johnson O
    Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.
    Chen DY; Chen YM; Hsieh TY; Hsieh CW; Lin CC; Lan JL
    Arthritis Res Ther; 2015 Mar; 17(1):52. PubMed ID: 25889426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis.
    Naerr GW; Rein P; Saely CH; Drexel H
    Vascul Pharmacol; 2016 Jun; 81():22-30. PubMed ID: 26903239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
    Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
    Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.
    Charles-Schoeman C; Gonzalez-Gay MA; Kaplan I; Boy M; Geier J; Luo Z; Zuckerman A; Riese R
    Semin Arthritis Rheum; 2016 Aug; 46(1):71-80. PubMed ID: 27079757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M; Nurmohamed MT; Wolbink G; Voskuyl AE; de Koning M; van de Stadt R; Twisk JW; Dijkmans BA; Lems WF
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.
    Cacciapaglia F; Anelli MG; Rinaldi A; Fornaro M; Lopalco G; Scioscia C; Lapadula G; Iannone F
    Mediators Inflamm; 2018; 2018():2453265. PubMed ID: 30405318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab.
    Raterman HG; Levels H; Voskuyl AE; Lems WF; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2013 Apr; 72(4):560-5. PubMed ID: 22589377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and lipid changes with synthetic and biologic disease-modifying antirheumatic drug therapy in rheumatoid arthritis: implications for cardiovascular risk.
    Myasoedova E
    Curr Opin Rheumatol; 2017 May; 29(3):277-284. PubMed ID: 28207495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study.
    Papamichail GV; Georgiadis AN; Tellis CC; Rapti I; Markatseli TE; Xydis VG; Tselepis AD; Drosos AA; Voulgari PV
    Clin Rheumatol; 2024 Jan; 43(1):481-488. PubMed ID: 37642764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis.
    van Sijl AM; Peters MJ; Knol DL; de Vet RH; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
    Semin Arthritis Rheum; 2011 Dec; 41(3):393-400. PubMed ID: 21665247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.
    Filippatos TD; Derdemezis CS; Voulgari PV; Tsimihodimos V; Elisaf MS; Tselepis AD; Drosos AA
    Scand J Rheumatol; 2013; 42(3):169-75. PubMed ID: 23311768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study.
    Papamichail GV; Markatseli TE; Georgiadis AN; Xydis VG; Milionis H; Drosos AA; Voulgari PV
    Heart Vessels; 2022 Dec; 37(12):2128-2136. PubMed ID: 35739432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.
    Park YB; Choi HK; Kim MY; Lee WK; Song J; Kim DK; Lee SK
    Am J Med; 2002 Aug; 113(3):188-93. PubMed ID: 12208376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.
    Steiner G; Urowitz MB
    Semin Arthritis Rheum; 2009 Apr; 38(5):372-81. PubMed ID: 18395771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs.
    Sánchez T; Contreras-Yáñez I; Elías-López D; Aguilar Salinas CA; Pascual-Ramos V
    Clin Exp Rheumatol; 2014; 32(4):509-15. PubMed ID: 25005131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.